kat: a high-efficiency retroviral transduction system for primary human T lymphocytes - PubMed (original) (raw)
. 1994 Jan 1;83(1):43-50.
Affiliations
- PMID: 8274751
Free article
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes
M H Finer et al. Blood. 1994.
Free article
Abstract
We describe a novel retroviral packaging system in which high titer amphotropic retrovirus was produced without the need to generate stable producer clones. kat expression vectors, which produce high levels of retroviral vector transcripts and retroviral packaging functions, were transfected into 293 cells followed by virus harvest 48 hours posttransfection. Viral titers as high as 3.8 proviral copies/cell/mL of frozen supernatant in 3T3 cells were obtained, 10- to 50-fold greater than transient viral titers reported using 3T3-based retroviral packaging lines. Cocultivation of primary human CD8+ T lymphocytes after transient transfection of 293 cells with kat plasmids resulted in transduction efficiencies of 10% to 40%, 5- to 10-fold greater compared to cocultivation with a high titer PA317 producer clone and significantly greater than previously reported results for transduction of primary human T lymphocytes with retroviral vectors. Virus produced using the kat system was shown to be free of detectable replication competent retrovirus by an extended provirus mobilization assay, demonstrating that this system is as safe as currently available stable packaging lines. The kat virus production system should be of general use for the rapid production of high titer viral supernatants, as well as for high-efficiency transduction hematopoietic cell types refractory to retroviral transduction.
Similar articles
- Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568 - Generation of retroviral vector for clinical studies using transient transfection.
Yang S, Delgado R, King SR, Woffendin C, Barker CS, Yang ZY, Xu L, Nolan GP, Nabel GJ. Yang S, et al. Hum Gene Ther. 1999 Jan 1;10(1):123-32. doi: 10.1089/10430349950019255. Hum Gene Ther. 1999. PMID: 10022537 - Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.
Yoshimatsu T, Tamura M, Kuriyama S, Ikenaka K. Yoshimatsu T, et al. Hum Gene Ther. 1998 Jan 20;9(2):161-72. doi: 10.1089/hum.1998.9.2-161. Hum Gene Ther. 1998. PMID: 9472776 - Production of high-titer retroviral vectors and detection of replication-competent retroviruses.
Kim YS, Lim HK, Kim KJ. Kim YS, et al. Mol Cells. 1998 Feb 28;8(1):36-42. Mol Cells. 1998. PMID: 9571629 - Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y, Miller WM, Aiyar A. Chen Y, et al. Biotechnol Prog. 2005 Jan-Feb;21(1):274-82. doi: 10.1021/bp049865x. Biotechnol Prog. 2005. PMID: 15903266 Free PMC article.
Cited by
- SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.
Zhang L, Friedman AD. Zhang L, et al. Blood. 2011 Aug 25;118(8):2266-74. doi: 10.1182/blood-2011-01-331157. Epub 2011 Jul 1. Blood. 2011. PMID: 21725048 Free PMC article. - Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.
Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R Jr, Marynen P, Gilliland DG. Schwaller J, et al. EMBO J. 1998 Sep 15;17(18):5321-33. doi: 10.1093/emboj/17.18.5321. EMBO J. 1998. PMID: 9736611 Free PMC article. - Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.
Yang OO, Tran AC, Kalams SA, Johnson RP, Roberts MR, Walker BD. Yang OO, et al. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11478-83. doi: 10.1073/pnas.94.21.11478. Proc Natl Acad Sci U S A. 1997. PMID: 9326635 Free PMC article. - LSK derived LSK- cells have a high apoptotic rate related to survival regulation of hematopoietic and leukemic stem cells.
Peng C, Chen Y, Shan Y, Zhang H, Guo Z, Li D, Li S. Peng C, et al. PLoS One. 2012;7(6):e38614. doi: 10.1371/journal.pone.0038614. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675576 Free PMC article. - Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation.
Frantsve J, Schwaller J, Sternberg DW, Kutok J, Gilliland DG. Frantsve J, et al. Mol Cell Biol. 2001 May;21(10):3547-57. doi: 10.1128/MCB.21.10.3547-3557.2001. Mol Cell Biol. 2001. PMID: 11313480 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials